Press release
Rising Cancer Incidence To Drive Market Growth: A Key Driver Powering Neulasta Market Growth In 2025
Neulasta Market
What Is the Current Neulasta Market Size and Its Estimated Growth Rate?
In recent years, the market size of neulasta has experienced a XX (HCAGR). Its growth is projected to climb from $XX million in 2024 to $XX million in 2025, boasting a compound annual growth rate (CAGR) of XX%. This substantial growth during the historic period can be linked to an array of factors such as a surge in chemotherapy-induced neutropenia, a rise in global cancer rates, increased awareness about the risks of neutropenia during cancer therapy, the existence of favorable government funding for biologics and the early acceptance of biologics in advanced regions.
The future years are expected to witness a significant increase in the neulasta market with a forecasted compound annual growth rate (FCAGR) of XX%. The market valuation is projected to reach $XX million by the year 2029, marking a CAGR of XX%. This anticipated uptrend during the forecast period stems from the growth of biosimilars in developing markets, burgeoning demand for economical supportive care for cancer, expansion in global healthcare spending, additional approvals of biosimilars from regulatory bodies, and heightened patient cognizance regarding biosimilar substitutes. Major projected trends within the forecast timeframe encompass the creation of prefilled syringes for simplified administration, advancements in drug delivery systems like on-body injectors, embracing digital platforms for patient knowledge enhancement, applying AI in biologics R&D and enhancing supply chain efficiency, and strategic alliances among biologic and biosimilar companies.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20159
How Are Emerging Segments Shaping the Neulasta Market Landscape?
The neulasta market covered in this report is segmented -
1) By Indication: Chemotherapy-Induced Neutropenia, Bone Marrow Transplantation, Other Indications
2) By Formulation: Injectable Solution, Pre-Filled Syringes Or Pens
3) By Distribution Channel: Hospitals, Oncology Clinics, Specialty Pharmacies, Home Healthcare Services
4) By End User Patients: Adult Patients, Pediatric Patients
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20159&type=smp
Which Growth Factors Are Influencing Neulasta Market Expansion?
The escalation in cancer cases is propelling the expansion of the neulasta market. Cancer is identified as a set of diseases with unusual cell growth with the potential to invade other parts of the body. The growth of cancer prevalence is attributed to elements such as aging populations, unhealthy lifestyles, and environmental factors. Pegfilgrastim biosimilars like neulasta are highly important for those undergoing cancer therapy as they mitigate the risk of chemotherapy-induced neutropenia by inducing white blood cell production and lowering infection risks. For example, projections from the Australian Institute of Health and Welfare in August 2024 suggest that by 2034, Australia may record around 209,000 new cancer diagnoses, a considerable surge from the predicted 169,000 cases in 2024. Furthermore, in 2024, it is predicted that cancer will cause approximately 3 out of every ten deaths in the nation. Thus, the growing occurrence of cancer is set to push forward the neulasta market.
Who Are the Dominant Players Across Different Neulasta Market Segments?
Major companies operating in the neulasta market include Amgen Inc.
What Are the Latest Developing Trends in the Adcetris Market?
One of the primary trends in the Neulasta industry is the expansion of drug delivery technologies, specifically prefilled autoinjectors, to enhance competitiveness. These autoinjectors, which come preloaded with medication, are designed for a comfortable and efficient patient self-administration. In March 2023, the biopharmaceutical company based in the US, Coherus Biosciences, announced that their single-dose, prefilled autoinjector version of the biosimilar pegfilgrastim - Udenyca (pegfilgrastim-cbqv), was approved by the FDA. It is designed for the treatment and prevention of febrile neutropenia, a common side effect of chemotherapy. With this autoinjector, patients can self-administer pegfilgrastim the day after chemotherapy, minimising the incidence of febrile neutropenia. The device is equipped with a push-on-skin mechanism for the immediate and reliable delivery of a complete pegfilgrastim dose.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/neulasta-global-market-report
Which Geographic Regions Are Expected to Dominate the Neulasta Market in the Coming Years?
North America was the largest region in the neulasta market in 2024. The regions covered in the neulasta market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Neulasta Market?
2. What is the CAGR expected in the Neulasta Market?
3. What Are the Key Innovations Transforming the Neulasta Industry?
4. Which Region Is Leading the Neulasta Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Cancer Incidence To Drive Market Growth: A Key Driver Powering Neulasta Market Growth In 2025 here
News-ID: 4063483 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for Neulasta
Neulasta Market Growth Driven by Oncology Care Advances and Biosimilar Entry, 20 …
The qualitative latest Research report (2025-2032) on the Neulasta Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/8171
Focused on growth and future…
Neulasta Market: An Analysis of Size, Shares, Business Growth, and Upcoming Tren …
The Neulasta Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Neulasta industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial…
Global Neulasta (Pegfilgrastim) And Biosimilar Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Neulasta (Pegfilgrastim) And Biosimilar market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for pegfilgrastim and biosimilars is expanding significantly, mostly due to the rising use of chemotherapy-based cancer treatments. By promoting the formation…
Rising Cancer Incidence To Drive Market Growth: A Key Factor Shaping the Future …
Which drivers are expected to have the greatest impact on the over the neulasta market's growth?
The neulasta market's growth is propelled by the increasing occurrence of cancer. Cancer, described as a collection of diseases with abnormal cell growth, can metastasize to other sections of the body. Various factors like aging demographics, unhealthy living habits, and environmental elements contribute to the rising cancer cases. Pegfilgrastim biosimilars like neulasta are essential for…
Key Driver Reshaping the Neulasta Market in 2025: Rising Cancer Incidence To Dri …
How Is the Neulasta Market Projected to Grow, and What Is Its Market Size?
In recent times, there's been an $XX expansion in the Neulasta market size. Starting with a worth of $XX million in 2024, it's projected to reach $XX million in 2025, progressing at a compound annual growth rate (CAGR) of $XX%. The evolution during this historic period is associated with the increasing instances of chemotherapy-induced neutropenia, rising cases…
Neulasta Pegfilgrastim and Biosimilar Market Trends, Size, Segments, Key Growth …
This report segments the Neulasta Pegfilgrastim and Biosimilar Market comprehensively. The regional market sizes, concerning products by type, by application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Neulasta Pegfilgrastim and Biosimilar Market Size was estimated at 10.59 (USD Billion)…
